Siemens Medical Solutions Diagnostics take you from Innovation to Proven Outcomes at IBMS Congress 2007

Siemens Medical Solutions Diagnostics, the health industry's first in-vivo and in-vitro diagnostics company, will be showing new products for near patient testing and greater laboratory productivity at the Institute of Biomedical Science (IBMS) Congress (24-26 September 2007, Birmingham, UK).

For near patient testing, IBMS Congress provides the official launch in the UK of the DCA Vantage, which combines the strengths of the DCA2000+ with added functionality to "future proof" the system for our current and future point of care environment.

DCA Vantage is a semi-automated, benchtop system, designed to quantitatively measure the percent Hemoglobin A1c in blood and low concentrations of albumin in urine (microalbuminuria), creatinine in urine, and the albumin/creatinine ratio in urine. Amongst the many new features provided by the DCA Vantage, users now have increased data storage (up to 4000 combined patient/control results records) and additional connectivity to improve connections to Laboratory Information Systems (LIS) and Hospital Information Systems (HIS). An integral printer also provides a hard copy of the patient results.

And for the first time, visitors to the Siemens Diagnostics stand will be able to preview the Clinitek Advantus – the next generation in urine chemistry analysis.